Approval · Notice of Compliance 33204 · 2024
APRETUDE: Notice of Compliance 33204
Issued May 13, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33204
- Date
- May 13, 2024
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
Products in this notice
Medicinal ingredients
- CABOTEGRAVIR 200 MG per ML
- CABOTEGRAVIR SODIUM 30 MG per TAB